• ECS increases NAB loan facility to $5.2 million
• Additional funding to support international launch of Terphogz cannabis products
• Revolving leasing facility increased by $0.4 million to cover power upgrades

ECS Botanics Holdings Ltd (ASX:ECS) has announced a $2 million increase in its loan facility with the National Australia Bank (NAB), bringing the total facility to $5.2 million. This additional funding will significantly bolster ECS's working capital, providing the necessary resources to support the international launch of the Terphogz product line. NAB has also increased ECS' revolving leasing facility by $0.4 million to cover the power upgrade associated with additional Protective Cropping Enclosures (PCE's). In September 2024, ECS entered an eight-year licensing and marketing agreement with Terphogz to expand its exceptional genetics, product portfolio, and brand beyond the Californian market. ECS has finalized an agreement with a UK partner to market and distribute Terphogz, with supply expected to commence mid-year. Additionally, late-stage negotiations are underway in Germany and New Zealand, with agreements anticipated to be executed in April following the finalisation of supply contracts. ECS aims to launch Terphogz in Australia via a B2C platform this quarter.

ECS looks forward to delivering this next phase of growth, supported by its partners, as it expands the Terphogz brand internationally.